271 related articles for article (PubMed ID: 16530291)
1. The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges.
Gans-Brangs KR; Plourde PV
Adv Drug Deliv Rev; 2006 Apr; 58(1):106-15. PubMed ID: 16530291
[TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
[TBL] [Abstract][Full Text] [Related]
3. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
4. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
5. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
6. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
7. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
[TBL] [Abstract][Full Text] [Related]
9. Pediatric regulatory initiatives.
Hirschfeld S; Saint-Raymond A
Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
[TBL] [Abstract][Full Text] [Related]
10. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
[TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
[TBL] [Abstract][Full Text] [Related]
12. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
13. Obtaining pediatric indications for new anti-epileptic drugs: how and when.
Garofalo E
Epilepsy Res; 2006 Jan; 68(1):38-42. PubMed ID: 16377135
[TBL] [Abstract][Full Text] [Related]
14. Ethical considerations in conducting pediatric research.
Roth-Cline M; Gerson J; Bright P; Lee CS; Nelson RM
Handb Exp Pharmacol; 2011; 205():219-44. PubMed ID: 21882114
[TBL] [Abstract][Full Text] [Related]
15. Conducting clinical trials in pediatrics.
Macrae D
Crit Care Med; 2009 Jan; 37(1 Suppl):S136-9. PubMed ID: 19104213
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy in pediatrics: a developing field.
Mathis L; Rodriguez W
Dermatol Ther; 2009; 22(3):257-61. PubMed ID: 19453350
[TBL] [Abstract][Full Text] [Related]
18. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(24):5551-2. PubMed ID: 14968802
[TBL] [Abstract][Full Text] [Related]
19. The march toward rational therapeutics in children.
Gorman RL
Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584
[TBL] [Abstract][Full Text] [Related]
20. Video: pediatric medicines--prescribing drugs "off-label".
Frederick R
Science; 2008 Oct; 322(5899):209. PubMed ID: 18845741
[No Abstract] [Full Text] [Related]
[Next] [New Search]